# Sharps Technology receives $30M purchase order from Nephron for prefillable syringes

Sharps Technology received a signed $30 million purchase order from Nephron Pharmaceuticals for 10mL and 50mL specialty copolymer prefillable syringes, covering the first 12 months of a five-year, $200 million sales agreement. The syringes will be manufactured at the West Columbia, South Carolina site being acquired from Nephron.

- Type: Contract
- Announced: 2024-06-13
- Where: West Columbia, South Carolina, United States
- Value: $30.0M
- Status: announced
- Products: prefillable copolymer syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sharps Technology](https://endata.com/companies/11050.md) (supplier)
- [Nephron Pharmaceuticals](https://endata.com/companies/11051.md) (customer)

## Sources

- [ir.sharpstechnology.com](https://ir.sharpstechnology.com/sharps-technology-receives-30-million-purchase-order-for-prefillable-copolymer-syringes-to-be-manufactured-at-sc-facility/), 2024-06-13: "Sharps Technology, Inc....received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments."
- [globenewswire.com](https://www.globenewswire.com/news-release/2024/06/13/2898262/0/en/sharps-technology-receives-30-million-purchase-order-for-prefillable-copolymer-syringes-to-be-manufactured-at-sc-facility.html), 2024-06-13: "Sharps Technology, Inc....received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.